Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 45, Issue 6, 2011, Pages 526-530

  Yamamoto, Shuji ^a,d   Nakase, Hiroshi ^a   Matsuura, Minoru ^a   Masuda, Satohiro ^b   Inui, Ken Ichi ^c   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

remission maintenance therapy; tacrolimus; thiopurines; ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AMINOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CREATININE BLOOD LEVEL; CYTAPHERESIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; GENITAL HERPES; HEADACHE; HOT FLUSH; HUMAN; HYPERKALEMIA; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREATITIS; PRIORITY JOURNAL; RELAPSE FREE SURVIVAL; REMISSION; SIDE EFFECT; SURVIVAL; TREMOR; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AZATHIOPRINE; COLITIS, ULCERATIVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958862495     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318209cdc4     Document Type: Article

References (17)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657. (Pubitemid 46722637)
2. Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42:16-25. (Pubitemid 46351421)
3. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260. (Pubitemid 32729372)
4. Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs. 1978;16:238-255. (Pubitemid 9001468)
5. Ogata H, Matsui T, Nakamura M, et al. A randomized dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis tacrolimus. Gut. 2006;55:1255-1262. (Pubitemid 44277355)
6. Baumgart DC, Pintoffl JP, Sturm A, et al. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - a long-term follow-up. Am J Gastroenterol. 2006;101:1048-1056. (Pubitemid 43725319)
7. Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis. 2002;8:317-324.
8. Ng SC, Arebi N, Kamm MA. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:129-134. (Pubitemid 46806220)
9. Yamamoto S, Nakase H, Mikami S, et al. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther. 2008;28:589-597.
10. Högenauer C, Wenzl HH, Hinterleitner TA, et al. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther. 2003;18:415-423. (Pubitemid 37070240)
11. Ziring DA, Wu SS, Mow WS, et al. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children. J Pediatr Gastroenterol Nutr. 2007;45:306-311. (Pubitemid 47415081)
12. Nakase H, Mikami S, Matsuura M, et al. Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy. Intern Med. 2007;46:717-720. (Pubitemid 46902266)
13. Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet. 1990;336:16-19. (Pubitemid 20207870)
14. Chebli LA, Chaves LD, Pimentel FF, et al. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis. Inflamm Bowel Dis. 2010;16:613-619.
15. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-489. (Pubitemid 34638866)
16. Langnas AN. Advances in small-intestine transplantation. Transplantation. 2004;15:S75-S78. (Pubitemid 38668463)
17. McMaster P, Mirza DF, Ismail T, et al. Therapeutic drug monitoring of tacrolimus in clinical transplantation. Ther Drug Monit. 1995;17:602-605.